Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment (2012)
- Authors:
- Autor USP: HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1177/0269881112444941
- Subjects: ESQUIZOFRENIA (FISIOPATOLOGIA); ANTIBIÓTICOS; ANTIPSICÓTICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Psychopharmacology
- ISSN: 0269-8811
- Volume/Número/Paginação/Ano: v. 26, n. 9, p. 1185-1193, 2012
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CHAUDHRY, Imran B. et al. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. Journal of Psychopharmacology, v. 26, n. 9, p. 1185-1193, 2012Tradução . . Disponível em: https://doi.org/10.1177/0269881112444941. Acesso em: 09 abr. 2026. -
APA
Chaudhry, I. B., Hallak, J. E. C., Husain, N., Minhas, F., Stirling, J., Richardson, P., et al. (2012). Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. Journal of Psychopharmacology, 26( 9), 1185-1193. doi:10.1177/0269881112444941 -
NLM
Chaudhry IB, Hallak JEC, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment [Internet]. Journal of Psychopharmacology. 2012 ; 26( 9): 1185-1193.[citado 2026 abr. 09 ] Available from: https://doi.org/10.1177/0269881112444941 -
Vancouver
Chaudhry IB, Hallak JEC, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment [Internet]. Journal of Psychopharmacology. 2012 ; 26( 9): 1185-1193.[citado 2026 abr. 09 ] Available from: https://doi.org/10.1177/0269881112444941 - Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine. [Carta]
- Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ?
- Disorganized symptoms predicted worse functioning outcome in schizophrenia patients with established illness
- Transtorno de pânico e outros medicamentos
- Psychedelics and Personality
- Nitric oxide’s involvement in the spectrum of psychotic disorders
- Effects of the natural β-carboline alkaloid harmine, a main constituent of Ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies
- An overview of animal models related to schizophrenia
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
- Cognition in at-risk mental states for psychosis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
